documents: FDA-2025-N-2976-0003

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2025-N-2976-0003 FDA FDA-2025-N-2976 Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine; Public Workshop; Request for Comments Notice Request for Comments 2025-11-24T05:00:00Z 2025 11 2025-11-24T05:00:00Z 2026-01-17T04:59:59Z 2026-01-17T13:20:26Z 2025-20658 0 0 09000064b909369d

Links from other tables